ArticleCurrent oncology (Toronto, Ont.)2024

Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond.

Febin Antony et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.